Contracts › HT942523C0078
HT942523C0078: Research and Development Services BA230121 Titled Self Assembling Vaccine Platform
Awarded to Hexamer Therapeutics Inc. by Defense Health Agency.
$3.9Mobligated
$3.9Mpotential value
31 March 2027current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | HT942523C0078 |
|---|---|
| Awardee | Hexamer Therapeutics Inc. |
| Awarding agency | Defense Health Agency |
| Awarding office | DEFENSE HEALTH AGENCY |
| NAICS | 541714 Research and Development in Biotechnology (Except Nanobiotechnology) |
| PSC | AN11 Health R&D Services; Health Care Services; Basic Research |
| Place of performance | WA |
| Offers received | 1 |
| Period of performance | 29 September 2023 to 31 March 2027 |
| Potential end | 31 March 2027 |
| Estimated recompete solicitation | Now / imminent (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 03 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541714 contracts · All expiring contracts · USASpending record